| NECOA Launches in Austin, Bets Americans Are Ready for a New Drinking Water Culture as EPA Renews Microplastic Concerns |
Globe Newswire |
04/20 |
09:00 |
| Velocity Logic Group and Paytronix Partner to Extend Loyalty Engagement to Every Pump Transaction |
Globe Newswire |
04/20 |
09:00 |
| Leverage Shares by Themes Announces ETF Share Splits |
Globe Newswire |
04/20 |
09:00 |
| Redis Introduces Redis Feature Form, an Enterprise Feature Store for Production Machine Learning |
Globe Newswire |
04/20 |
09:00 |
| Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury |
Globe Newswire |
04/20 |
09:00 |
| Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond |
Globe Newswire |
04/20 |
09:00 |
| Alchip Appoints Freddy Engineer Chief Business Officer and North America General Manager |
Globe Newswire |
04/20 |
09:00 |
| Portnoy Law Firm Announces Class Action on Behalf of Camping World Holdings, Inc. Investors |
Globe Newswire |
04/20 |
09:00 |
| Portnoy Law Firm Announces Class Action on Behalf of Concorde International Group, Ltd. Investors |
Globe Newswire |
04/20 |
09:00 |
| Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics |
Globe Newswire |
04/20 |
09:00 |
| $29.6+ BN Life Sciences Consulting Services Market Forecasts to 2034: Rising Drug Complexity, AI & Big Data Adoption, Demand for Real-World Evidence, and Biotech Expansion with Novel Therapies |
Globe Newswire |
04/20 |
08:59 |
| INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:55 |
| INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:53 |
| CORT FINAL DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure |
Globe Newswire |
04/20 |
08:46 |
| INVESTOR NOTICE: Lufax Holding (LU) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:45 |
| INVESTOR NOTICE: Gemini Space Station (GEMI) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:43 |
| INVESTOR NOTICE: Coty Inc. (COTY) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:43 |
| INVESTOR DEADLINE: Navan, Inc. (NAVN) Investors with Substantial Losses Have Opportunity to Lead the Navan Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:41 |
| INVESTOR NOTICE: Hercules Capital (HTGC) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action – Hagens Berman |
Globe Newswire |
04/20 |
08:39 |
| AI & Technology Virtual Investor Conference Agenda Announced for April 23rd |
Globe Newswire |
04/20 |
08:35 |
| Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing |
Globe Newswire |
04/20 |
08:35 |
| INVESTOR DEADLINE: Trip.com Group (TCOM) Investors with Substantial Losses Have Opportunity to Lead the Trip.com Class Action Lawsuit– Hagens Berman |
Globe Newswire |
04/20 |
08:33 |
| INVESTOR NOTICE: ODDITY Tech. (ODD) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action– Hagens Berman |
Globe Newswire |
04/20 |
08:33 |
| Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026 |
Globe Newswire |
04/20 |
08:32 |
| INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action – Hagens Berman |
Globe Newswire |
04/20 |
08:30 |
